Cite
HARVARD Citation
Sugano, T. et al. (2020). Immune checkpoint inhibitor‐associated interstitial lung diseases correlate with better prognosis in patients with advanced non‐small‐cell lung cancer. Thoracic cancer. 11 (4), pp. 1052-1060. [Online].